Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.
about
Protein substitute for children and adults with phenylketonuriaProtein substitute for children and adults with phenylketonuriaNutritional Management of PhenylketonuriaAge-related psychophysiological vulnerability to phenylalanine in phenylketonuria.Central precocious puberty in a 3 year-old girl with Phenylketonuria: a rare association?Extensive alterations of blood metabolites in pediatric cerebral malaria.Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice.Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria.Communicative and psycholinguistic abilities in children with phenylketonuria and congenital hypothyroidismWhen should social service referral be considered in phenylketonuria?Response monitoring in children with phenylketonuria.Predictive equations underestimate resting energy expenditure in female adolescents with phenylketonuria.Dietary habits and metabolic control in adolescents and young adults with phenylketonuria: self-imposed protein restriction may be harmful.Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.Phenylalanine hydroxylase deficiency.Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuriaMetabolome-wide association study of phenylalanine in plasma of common marmosets"MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trialThe potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseasesUp to date knowledge on different treatment strategies for phenylketonuria.Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.Assessing Psychological Functioning in Metabolic Disorders: Validation of the Adaptive Behavior Assessment System, Second Edition (ABAS-II), and the Behavior Rating Inventory of Executive Function (BRIEF) for Identification of Individuals at RiskAssessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.Outcomes of phenylketonuria with relevance to follow-upDepression and anxiety among parents of phenylketonuria childrenThe neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of PhenylketonuriaSocial-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO studyTetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype.A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation.The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria.Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.Motor development skills of 1- to 4-year-old Iranian children with early treated phenylketonuriaRecommendations for the nutrition management of phenylalanine hydroxylase deficiency.Newborn screening 50 years later: access issues faced by adults with PKU.Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria.Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaireNeurocognitive function in mild hyperphenylalaninemia.Extremely high phenylalanine levels in a newborn on parenteral nutrition: phenylketonuria in the neonatal intensive care unit.Molecular genetics and diagnosis of phenylketonuria: state of the art.
P2860
Q24187935-BCB7AC10-7D8F-4D58-AF10-3ECBF2D39A24Q24241445-FA5A1E78-A4D7-4F5A-8113-71333B3A4D44Q24613843-DADF8FE9-237F-4775-84AC-5A314BE3EAF7Q30435275-2FC3D5C5-5F1D-4799-88C5-874920D9B098Q33578240-C751D90E-71CB-4FDD-8F43-53A1B6D84E7CQ33584763-81AED5B2-3FCE-4448-B7C5-5E22248DE6FEQ33603240-A7C622A9-40BD-4819-B4B8-F8784EDA20C2Q33627501-A9D961C3-FCF5-443B-B4C1-083BC584B3DCQ33786985-5184F1DC-4843-4582-8537-E58F9F881A6FQ33799097-63D6E915-E57C-46BE-AFA4-A1353DF77F40Q33828176-B829FA48-2E7F-4740-B63C-F11EBE9F1017Q33913673-1836F93B-0D4E-4AE7-9D31-ABFB6375EFC0Q33947347-B0F9FE13-545F-46A2-8599-5008270596A7Q34088589-5B418534-781A-427D-8FCF-A1D7CFC02466Q34183829-EE63AD84-042F-4D24-8D1E-1566615C2B40Q35079956-C41D6C4E-C9BD-4514-B2CC-8A0481A0B446Q35085238-CEB25787-A0AA-4990-8220-6EA53A3945E6Q35097062-E58F1B9D-2DBA-4DB8-AE0B-6D1D1C72AC3CQ35145713-7AFB4F32-4B19-4E62-A6B6-10086026F71CQ35623929-963F2526-89A6-44B7-B3F3-6F8DB47A8867Q35666961-6DCBD481-62AB-443C-9030-23ACB2806D45Q35752470-144A6719-FB40-448C-81AC-F7A1C413A48BQ35972805-783CB65A-7B1F-4C5A-A750-B96B8336CF18Q36433235-162A1568-9FC3-4894-A973-CE4C9292B2E7Q36504505-8580684B-08C0-491E-96C8-3AA624473018Q36517618-E605A1FB-8E78-4285-AA81-15D45296052DQ36846193-1D752736-353C-493E-8CDE-286313436C67Q36853467-94979BB1-2B09-416D-A99A-29E9F0F071F9Q37014366-AA7C3CA3-68BB-414D-B7AB-4CAB3769205EQ37043333-DE4DEA3F-16AB-404F-B10D-76D8C089F2ACQ37410883-ECBD3FDE-9F0D-4398-98C3-E95B06BDDC93Q37494824-85B1EFE9-7570-4D07-9226-83E3FDD0A2DBQ37500652-DA2299DB-F312-4C11-AB47-EE618FF32CFBQ37570443-EC3AF0D0-E5B5-460C-9154-FF202FFD0C87Q37609467-12C662A0-2124-4033-8C81-BCD9C3F53070Q37662793-9818DF2A-0B9E-4D2B-AEE9-9F710D80C2EBQ37690085-6AC0CB93-A62F-4BF1-B735-84A3EEF17C36Q37854819-58535769-5F6E-429C-9883-5160404AD503Q37895456-8CCD003E-68E8-462A-B430-6C0D4BF4827AQ38216515-B5F1647E-E58F-4015-8B85-F4F0478880CB
P2860
Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Phenylalanine blood levels and ...... ture review and meta-analysis.
@en
type
label
Phenylalanine blood levels and ...... ture review and meta-analysis.
@en
prefLabel
Phenylalanine blood levels and ...... ture review and meta-analysis.
@en
P2093
P1476
Phenylalanine blood levels and ...... ture review and meta-analysis.
@en
P2093
Alex Dorenbaum
Catherine Cella
Diana Frame
Harvey Levy
Kyle Fahrbach
Susan E Waisbren
P356
10.1016/J.YMGME.2007.05.006
P577
2007-06-25T00:00:00Z